Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

NeuroPace

Explore full profile

Developing and marketing implantable devices for the treatment of neurological disorders

Mountain View, United StatesFounded 1999Health Tech & Medtech
Valuation $456M Market cap · 2026
Revenue $100M Latest reported FY
Total funding $100–500M Disclosed equity funding

About NeuroPace

NeuroPace is a medical device company that has developed a brain-responsive neuromodulation system for treating epilepsy. This system, known as the RNS System, is designed to monitor and respond to a patient's brain activity to prevent seizures. The company's primary market is individuals with refractory epilepsy, a form of the condition that does not respond to medication.

Read full description

The RNS System is an implantable device that provides personalized treatment by delivering electrical stimulation to the brain when it detects abnormal activity. This approach is intended to reduce the frequency and severity of seizures, improving the quality of life for patients. The company operates on a business model that involves the sale of these devices to healthcare facilities and providing ongoing support and data analysis services.

NeuroPace is a publicly traded company, and its revenue is generated through the sale of the RNS System and related components. The company is focused on expanding the adoption of its technology and continuing to develop its platform for other neurological disorders.

Source: Dealroom company data

At a glance

Founded
1999
Headquarters
Mountain View, United States
Listing
IPO 2021
Sector
Health Tech & Medtech
Power Law
Colt$25–100M revenue

Latest news

Press, funding announcements and product moves mentioning NeuroPace.

See all news

Investors

16 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Series B and later15 investors entered at this stage

  • Technology Partners
  • Domain Associates
  • Medventure
  • NEA
  • InterWest Partners
  • Johnson & Johnson
  • MedVenture Associates
  • Johnson & Johnson Development Corporation
  • OrbiMed
  • KCK
  • Armentum Partners
  • Soleus Capital
  • Accelmed
  • Revelation Partners
  • Midcap Financial

Talent

Book a demo to see the people
Employees mapped 245 incl. 4 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States99.4%
🇧🇷 Brazil0.6%
2 countries shown
Web traffic by country
17K monthly visits
across markets
🇺🇸 United States66.5%
🇨🇦 Canada13.5%
🇬🇧 United Kingdom8.8%
🇮🇳 India5.9%
🇦🇺 Australia3.5%
Top 5 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about NeuroPace on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NeuroPace on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles